Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer.

Ding H, Yusof AM, Kothandaraman S, Saji M, Wang C, Kumar K, Milum K, Carleton M, Pan X, Ringel MD, Tweedle MF, Phay JE.

J Clin Endocrinol Metab. 2013 Nov;98(11):E1722-9. doi: 10.1210/jc.2013-1756. Epub 2013 Sep 12.

PMID:
24030941
[PubMed - indexed for MEDLINE]
2.

Development of a calcium-sensing receptor molecular imaging agent.

Yusof AM, Kothandaraman S, Zhang X, Saji M, Ringel MD, Tweedle MF, Phay JE.

Surgery. 2013 Dec;154(6):1378-84; discussion 1384. doi: 10.1016/j.surg.2013.06.044.

PMID:
24238055
[PubMed - indexed for MEDLINE]
3.

Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.

Behr TM, Jenner N, Béhé M, Angerstein C, Gratz S, Raue F, Becker W.

J Nucl Med. 1999 Jun;40(6):1029-44.

PMID:
10452322
[PubMed - indexed for MEDLINE]
Free Article
4.

Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptor.

Koh J, Dar M, Untch BR, Dixit D, Shi Y, Yang Z, Adam MA, Dressman H, Wang X, Gesty-Palmer D, Marks JR, Spurney R, Druey KM, Olson JA Jr.

Mol Endocrinol. 2011 May;25(5):867-76. doi: 10.1210/me.2010-0277. Epub 2011 Mar 10.

PMID:
21393447
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Recombinant leukemia inhibitory factor suppresses human medullary thyroid carcinoma cell line xenografts in mice.

Starenki D, Singh NK, Jensen DR, Peterson FC, Park JI.

Cancer Lett. 2013 Oct 1;339(1):144-51. doi: 10.1016/j.canlet.2013.07.006. Epub 2013 Jul 12.

PMID:
23856028
[PubMed - indexed for MEDLINE]
6.

N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity.

Kessler A, Faure H, Petrel C, Rognan D, Césario M, Ruat M, Dauban P, Dodd RH.

J Med Chem. 2006 Aug 24;49(17):5119-28.

PMID:
16913701
[PubMed - indexed for MEDLINE]
7.

Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.

Kraeber-Bodéré F, Bodet-Milin C, Niaudet C, Saï-Maurel C, Moreau A, Faivre-Chauvet A, Thomare P, Deleris G, Estieu-Gionnet K, Bikfalvi A, Barbet J, Paris F.

J Nucl Med. 2010 Apr;51(4):624-31. doi: 10.2967/jnumed.109.070714.

PMID:
20351352
[PubMed - indexed for MEDLINE]
Free Article
8.

Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer.

Rogers BE, Rosenfeld ME, Khazaeli MB, Mikheeva G, Stackhouse MA, Liu T, Curiel DT, Buchsbaum DJ.

J Nucl Med. 1997 Aug;38(8):1221-9.

PMID:
9255155
[PubMed - indexed for MEDLINE]
Free Article
9.

Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cells.

Avlani VA, Ma W, Mun HC, Leach K, Delbridge L, Christopoulos A, Conigrave AD.

Am J Physiol Endocrinol Metab. 2013 May 15;304(10):E1097-104. doi: 10.1152/ajpendo.00054.2013. Epub 2013 Mar 26.

PMID:
23531616
[PubMed - indexed for MEDLINE]
Free Article
10.

Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.

Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.

Clin Cancer Res. 1999 Oct;5(10 Suppl):3124s-3138s.

PMID:
10541353
[PubMed - indexed for MEDLINE]
11.
12.

The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.

Casalà C, Gil-Guiñón E, Ordóñez JL, Miguel-Queralt S, Rodríguez E, Galván P, Lavarino C, Munell F, de Alava E, Mora J, de Torres C.

Carcinogenesis. 2013 Feb;34(2):268-76. doi: 10.1093/carcin/bgs338. Epub 2012 Oct 29.

PMID:
23108190
[PubMed - indexed for MEDLINE]
Free Article
13.

Beta-arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitization.

Pi M, Oakley RH, Gesty-Palmer D, Cruickshank RD, Spurney RF, Luttrell LM, Quarles LD.

Mol Endocrinol. 2005 Apr;19(4):1078-87. Epub 2005 Jan 6.

PMID:
15637145
[PubMed - indexed for MEDLINE]
14.

Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector.

Rogers BE, Curiel DT, Mayo MS, Laffoon KK, Bright SJ, Buchsbaum DJ.

Cancer. 1997 Dec 15;80(12 Suppl):2419-24.

PMID:
9406692
[PubMed - indexed for MEDLINE]
15.

Recent updates on the calcium-sensing receptor as a drug target.

Trivedi R, Mithal A, Chattopadhyay N.

Curr Med Chem. 2008;15(2):178-86. Review.

PMID:
18220773
[PubMed - indexed for MEDLINE]
16.

Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer.

De Falco V, Buonocore P, Muthu M, Torregrossa L, Basolo F, Billaud M, Gozgit JM, Carlomagno F, Santoro M.

J Clin Endocrinol Metab. 2013 May;98(5):E811-9. doi: 10.1210/jc.2012-2672. Epub 2013 Mar 22.

PMID:
23526464
[PubMed - indexed for MEDLINE]
17.

Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.

Spitzweg C, Baker CH, Bergert ER, O'Connor MK, Morris JC.

Hum Gene Ther. 2007 Oct;18(10):916-24.

PMID:
17931047
[PubMed - indexed for MEDLINE]
18.

Biodistribution of free 211At and 125I- in nude mice bearing tumors derived from anaplastic thyroid carcinoma cell lines.

Lundh C, Lindencrona U, Schmitt A, Nilsson M, Forssell-Aronsson E.

Cancer Biother Radiopharm. 2006 Dec;21(6):591-600.

PMID:
17257074
[PubMed - indexed for MEDLINE]
19.

Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma.

Cuccuru G, Lanzi C, Cassinelli G, Pratesi G, Tortoreto M, Petrangolini G, Seregni E, Martinetti A, Laccabue D, Zanchi C, Zunino F.

J Natl Cancer Inst. 2004 Jul 7;96(13):1006-14.

PMID:
15240784
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk